Lv et al. demonstrated in a mouse model of colorectal cancer that a knockdown of EFTUD2 resulted in a reduced secretion of proinflammatory cytokines and tumorigenic factors (Lv et al. 2019). This evidence concerns the gene EFTUD2 and colorectal cancer.